Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12163055rdf:typepubmed:Citationlld:pubmed
pubmed-article:12163055lifeskim:mentionsumls-concept:C0242275lld:lifeskim
pubmed-article:12163055lifeskim:mentionsumls-concept:C0023467lld:lifeskim
pubmed-article:12163055lifeskim:mentionsumls-concept:C0016030lld:lifeskim
pubmed-article:12163055lifeskim:mentionsumls-concept:C0934502lld:lifeskim
pubmed-article:12163055lifeskim:mentionsumls-concept:C1510411lld:lifeskim
pubmed-article:12163055lifeskim:mentionsumls-concept:C0205245lld:lifeskim
pubmed-article:12163055lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:12163055lifeskim:mentionsumls-concept:C0018270lld:lifeskim
pubmed-article:12163055lifeskim:mentionsumls-concept:C1527148lld:lifeskim
pubmed-article:12163055lifeskim:mentionsumls-concept:C0443199lld:lifeskim
pubmed-article:12163055pubmed:issue10lld:pubmed
pubmed-article:12163055pubmed:dateCreated2002-8-6lld:pubmed
pubmed-article:12163055pubmed:abstractTextThe hematopoietic supporting abilities are known to be impaired in marrow stromal layers developed from patients with acute myeloid leukemia (AML). In this study, fibroblast growth factor-4 (FGF-4), epidermal growth factor (EGF) or transforming growth factor-beta1 (TGF-beta1) were studied to see whether these growth factors can modify the functional development of leukemic stromal layers. Adherent stromal layers from 13 patients with AML and from six non-leukemic controls were established with 3ng/ml of FGF-4, EGF or TGF-beta1. Established stromal layers were washed three times and irradiated, followed by recharge of allogenic peripheral CD34 positive cells as an indicator of supportive function. Progenitor-outputs into supernatant were evaluated at biweekly interval with colony-forming assay until 6 weeks. The results showed that both leukemic and non-leukemic stromal cells established with FGF-4, but not with EGF, showed significantly higher progenitor cell-outputs compared with control stromal cells. By contrast, stromal cells developed with TGF-beta1 showed significantly lower progenitor cell-outputs compared with control. These differences were significant at later than 4 weeks after the recharge of indicator cells, suggesting that the stromal layer developed with EGF or TGF-beta1 preferentially affected the primitive progenitors rather than committed ones. These results indicate that FGF-4 and TGF-beta1 differentially affect the functional development of leukemic as well as of normal stromal layers.lld:pubmed
pubmed-article:12163055pubmed:languageenglld:pubmed
pubmed-article:12163055pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12163055pubmed:citationSubsetIMlld:pubmed
pubmed-article:12163055pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12163055pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12163055pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12163055pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12163055pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12163055pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12163055pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12163055pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12163055pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12163055pubmed:statusMEDLINElld:pubmed
pubmed-article:12163055pubmed:monthOctlld:pubmed
pubmed-article:12163055pubmed:issn0145-2126lld:pubmed
pubmed-article:12163055pubmed:authorpubmed-author:YamaneTakahis...lld:pubmed
pubmed-article:12163055pubmed:authorpubmed-author:HinoMasayukiMlld:pubmed
pubmed-article:12163055pubmed:authorpubmed-author:OhtaKensukeKlld:pubmed
pubmed-article:12163055pubmed:authorpubmed-author:TatsumiNoriyu...lld:pubmed
pubmed-article:12163055pubmed:authorpubmed-author:TakuboTakayuk...lld:pubmed
pubmed-article:12163055pubmed:authorpubmed-author:KohKi-RyangKRlld:pubmed
pubmed-article:12163055pubmed:authorpubmed-author:NakamaeHirohi...lld:pubmed
pubmed-article:12163055pubmed:issnTypePrintlld:pubmed
pubmed-article:12163055pubmed:volume26lld:pubmed
pubmed-article:12163055pubmed:ownerNLMlld:pubmed
pubmed-article:12163055pubmed:authorsCompleteYlld:pubmed
pubmed-article:12163055pubmed:pagination933-8lld:pubmed
pubmed-article:12163055pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12163055pubmed:meshHeadingpubmed-meshheading:12163055...lld:pubmed
pubmed-article:12163055pubmed:meshHeadingpubmed-meshheading:12163055...lld:pubmed
pubmed-article:12163055pubmed:meshHeadingpubmed-meshheading:12163055...lld:pubmed
pubmed-article:12163055pubmed:meshHeadingpubmed-meshheading:12163055...lld:pubmed
pubmed-article:12163055pubmed:meshHeadingpubmed-meshheading:12163055...lld:pubmed
pubmed-article:12163055pubmed:meshHeadingpubmed-meshheading:12163055...lld:pubmed
pubmed-article:12163055pubmed:meshHeadingpubmed-meshheading:12163055...lld:pubmed
pubmed-article:12163055pubmed:meshHeadingpubmed-meshheading:12163055...lld:pubmed
pubmed-article:12163055pubmed:meshHeadingpubmed-meshheading:12163055...lld:pubmed
pubmed-article:12163055pubmed:meshHeadingpubmed-meshheading:12163055...lld:pubmed
pubmed-article:12163055pubmed:meshHeadingpubmed-meshheading:12163055...lld:pubmed
pubmed-article:12163055pubmed:meshHeadingpubmed-meshheading:12163055...lld:pubmed
pubmed-article:12163055pubmed:meshHeadingpubmed-meshheading:12163055...lld:pubmed
pubmed-article:12163055pubmed:meshHeadingpubmed-meshheading:12163055...lld:pubmed
pubmed-article:12163055pubmed:meshHeadingpubmed-meshheading:12163055...lld:pubmed
pubmed-article:12163055pubmed:meshHeadingpubmed-meshheading:12163055...lld:pubmed
pubmed-article:12163055pubmed:meshHeadingpubmed-meshheading:12163055...lld:pubmed
pubmed-article:12163055pubmed:meshHeadingpubmed-meshheading:12163055...lld:pubmed
pubmed-article:12163055pubmed:meshHeadingpubmed-meshheading:12163055...lld:pubmed
pubmed-article:12163055pubmed:meshHeadingpubmed-meshheading:12163055...lld:pubmed
pubmed-article:12163055pubmed:meshHeadingpubmed-meshheading:12163055...lld:pubmed
pubmed-article:12163055pubmed:meshHeadingpubmed-meshheading:12163055...lld:pubmed
pubmed-article:12163055pubmed:meshHeadingpubmed-meshheading:12163055...lld:pubmed
pubmed-article:12163055pubmed:meshHeadingpubmed-meshheading:12163055...lld:pubmed
pubmed-article:12163055pubmed:year2002lld:pubmed
pubmed-article:12163055pubmed:articleTitleDifferential effects of fibroblast growth factor-4, epidermal growth factor and transforming growth factor-beta1 on functional development of stromal layers in acute myeloid leukemia.lld:pubmed
pubmed-article:12163055pubmed:affiliationClinical Hematology and Clinical Diagnostics, Graduate School of Medicine, Osaka City University, 1-4-3, Asahimachi, Abeno-ku, Osaka, Japan.lld:pubmed
pubmed-article:12163055pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12163055pubmed:publicationTypeComparative Studylld:pubmed
entrez-gene:1950entrezgene:pubmedpubmed-article:12163055lld:entrezgene
entrez-gene:7040entrezgene:pubmedpubmed-article:12163055lld:entrezgene
entrez-gene:2249entrezgene:pubmedpubmed-article:12163055lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12163055lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12163055lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12163055lld:entrezgene
lhgdn:association:6851lhgdn:found_inpubmed-article:12163055lld:lhgdn
lhgdn:association:40439lhgdn:found_inpubmed-article:12163055lld:lhgdn
lhgdn:association:55728lhgdn:found_inpubmed-article:12163055lld:lhgdn